Ashwagandha Brain Body Relax
Food supplement declared in France, decision dated 24 December 2025
Ashwagandha Brain Body Relax is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- Vimergy Europe B.V.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 50 gouttes (2 ml, 2 pipettes)
- Directions for use
- Jusqu’à 50 gouttes (2 ml, 2 pipettes) par jour, à diluer dans environ 150 ml d'eau.
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Autre : métabolisme énergétique, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Autre : métabolisme énergétique
Declaration 348985, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Withania somnifera (L.) Dunal | Racine | Extrait sec aqueux | 250 mg |
Additives
E422
Other ingredients
jus de citron, Eau purifiée
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. Ne pas utiliser si le sceau de sécurité du flacon est manquant ou endommagé. Agitez bien avant utilisation. Les compléments alimentaires ne doivent pas être utilisés comme substituts d’une alimentation variée et équilibrée et d’un mode de vie sain. Une consommation excessive peut avoir des effets laxatifs. Déconseillé aux femmes enceintes ou allaitantes, aux personnes de moins de 18 ans, aux personnes atteintes de troubles endocriniens (particulièrement les dysthyroïdies et l’hyperandrogénie), aux personnes atteintes de troubles hépatiques ou cardiaques et en cas de conduite de véhicules ou l’utilisation de machines et/ou en association avec des substances à action dépressive du système nerveux central. Tenir hors de la portée des jeunes enfants. Conserver dans un endroit frais et sec.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Withania somnifera (L.) Dunal
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.